Pulmatrix Inc (PULM)
6.12
+0.01
(+0.16%)
USD |
NASDAQ |
Nov 22, 16:00
6.145
+0.02
(+0.41%)
After-Hours: 20:00
Pulmatrix Enterprise Value: 11.57M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 11.57M |
| November 21, 2024 | 11.53M |
| November 20, 2024 | 9.744M |
| November 19, 2024 | 9.05M |
| November 18, 2024 | 13.76M |
| November 15, 2024 | 13.18M |
| November 14, 2024 | 6.384M |
| November 13, 2024 | 2.220M |
| November 12, 2024 | -3.295M |
| November 11, 2024 | -3.225M |
| November 08, 2024 | -3.295M |
| November 07, 2024 | -3.185M |
| November 06, 2024 | -3.003M |
| November 05, 2024 | -3.258M |
| November 04, 2024 | -3.190M |
| November 01, 2024 | -3.003M |
| October 31, 2024 | -2.747M |
| October 30, 2024 | -2.82M |
| October 29, 2024 | -2.82M |
| October 28, 2024 | -3.149M |
| October 25, 2024 | -3.405M |
| October 24, 2024 | -3.477M |
| October 23, 2024 | -3.295M |
| October 22, 2024 | -3.514M |
| October 21, 2024 | -3.331M |
| Date | Value |
|---|---|
| October 18, 2024 | -3.403M |
| October 17, 2024 | -3.368M |
| October 16, 2024 | -3.002M |
| October 15, 2024 | -3.149M |
| October 14, 2024 | -3.076M |
| October 11, 2024 | -3.029M |
| October 10, 2024 | -2.930M |
| October 09, 2024 | -2.966M |
| October 08, 2024 | -3.222M |
| October 07, 2024 | -2.966M |
| October 04, 2024 | -3.112M |
| October 03, 2024 | -3.149M |
| October 02, 2024 | -3.404M |
| October 01, 2024 | -3.076M |
| September 30, 2024 | -2.966M |
| September 27, 2024 | -4.563M |
| September 26, 2024 | -4.965M |
| September 25, 2024 | -4.855M |
| September 24, 2024 | -4.892M |
| September 23, 2024 | -4.454M |
| September 20, 2024 | -4.380M |
| September 19, 2024 | -4.344M |
| September 18, 2024 | -4.636M |
| September 17, 2024 | -4.417M |
| September 16, 2024 | -4.855M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-33.89M
Minimum
Mar 01 2022
86.73M
Maximum
Feb 16 2021
-8.611M
Average
-11.78M
Median
Jan 08 2024
Enterprise Value Benchmarks
| Entero Therapeutics Inc | 63.47M |
| Johnson & Johnson | 389.04B |
| Savara Inc | 383.75M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.587M |
| Revenue (Quarterly) | 0.366M |
| Total Expenses (Quarterly) | 3.023M |
| EPS Diluted (Quarterly) | -0.71 |
| Profit Margin (Quarterly) | -706.8% |
| Earnings Yield | -43.14% |
| Normalized Earnings Yield | -31.42 |